20
5n Plus Lubeck Gmbh, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BISMUTH SUBCITRATE POTASSIUM, with a corresponding US DMF Number 30295.
Remarkably, this DMF maintains an Active status since its submission on September 06, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2022, and payment made on February 22, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II